Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7785627B2 · kind B2 · utility
4Cited by
53References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 19, 2003 |
| Grant date | Aug 31, 2010 |
| Priority date | — |
| Expiry date | Jul 31, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative is herein disclosed and described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.